Skip to main
CANF
CANF logo

Can-Fite BioPharma Ltd. (CANF)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CANF Stock

About Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Market cap$13.89M
Today's volume6
Revenue (TTM)
Avg. daily volume279.01K
EBITDA (TTM)
Open$1.08
Price / earnings ratio-0.58x
Today's range$1.05 - $1.09
Debt / equity
52 week range$0.98 - $4.69
5 year debt / equity0.47x
Beta (LTM)0.51x
Interest coverage-580.71x
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsJan 3, 2025
Dividend payable date

CANF Stock Rating

What analysts recommend for CANF stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for CANF stock is $13.89M

The current P/E ratio for CANF stock is -0.58

The 52-week high for CANF stock is $4.69. The current CANF stock price $undefined is 100.00% below its 52-week high

The 52-week low for CANF stock is $0.98. The current CANF stock price $undefined has increased 100.00% from its 52-week low

No, the CANF stock does not pay dividends to its shareholders

The target price for CANF stock is $9.33 based on the average of what a group of analyst think CANF stock could be worth at a future date. This is not a prediction by Public.com

How to buy CANF stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CANF stock

    Navigate to the Explore page. Then, type CANF into the search bar. When you see CANF stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CANF stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Can-Fite BioPharma Ltd. Stock Earnings

The value each CANF share was expected to gain vs. the value that each CANF share actually gained.

CANF (CANF) reported Q4 2023 earnings per share (EPS) of -$0.01, beating estimates of -$0.26 by 96.15%. In the same quarter last year, CANF's earnings per share (EPS) was -$1.11. CANF is expected to release next earnings on 01/03/2025, with an earnings per share (EPS) estimate of -$1.60.

Buy CANF Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.